Dr Kevin Wing
BSc MSc PhD
I initially trained as a Biochemist, graduating from Bristol University with a BSc (Hons) in 1998. I subsequently completed an MSc in Information Technology at Glasgow University. I have 10 years experience working on technology and processes relating to the licensing and regulation of medicines. In 2010 I completed the MSc Epidemiology at LSHTM and completed my PhD at LSHTM in October 2015.
I am co-Course Organiser for the Certificate of Pharmacoepidemiology and Pharmacovigilance (PEPI) and a tutor on the DL Statistical Methods in Epidemiology MSc module (EPM202).
I have a general interest in the use of data collected as part of routine clinical care for studies of epidemiology and pharmacoepidemiology. My current main area of research focuses on how the preparation and analysis of randomised controlled trial-analogous cohorts in non-interventional data can be used to help improve the understanding of drug treatment effects in people who were underrepresented or excluded from trials. This has included a focus on Chronic Obstructive Pulmonary Disease (COPD) drug treatment effects within UK primary and secondary care, and I am also involved in projects utilising similar approaches for studying the treatment effects of cardiovascular drugs.
Other research I am either involved in currently or have worked on recently includes investigation of techniques relating to quantitative bias analysis, improving standards for performing pharmacoepidemiological research, quantification of the risk of serious drug-induced liver injury associated with a range of drug treatments, and studies of Ebola using data collected as part of clinical care during and after the 2013-16 West African outbreak. During the COVID-19 pandemic I have been involved in research using the OpenSAFELY platform, including looking at the effect of household composition on COVID-19 outcomes by ethnicity, the dffering risk of severe outcomes by SARS-CoV-variant and COVID survival and diabetes.